Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Canopy Growth's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Canopy Growth's regulatory disclosures and financial reporting.
Canopy Growth Corp director M. Shan Atkins reported a tax-related share sale linked to RSU vesting. On June 26, 2026, 3,197 common shares were disposed of at an average price of $0.9237 per share. According to the footnote, this disposition was associated with tax obligations arising from the vesting of restricted stock units granted on June 17, 2026.
After this transaction, Atkins directly holds 146,517 common shares. Because the filing describes the sale as tied to tax obligations on equity compensation, it reflects a routine administrative event rather than a discretionary open-market change in ownership.
Canopy Growth Corp director David Angelo Lazzarato reported a sale of 22,674 Common Shares at $0.9237 per share. According to the footnote, these shares were disposed of to cover tax obligations tied to the vesting of restricted stock units granted on June 17, 2026. After this transaction, he directly holds 211,859 Common Shares.
ATKINS M SHAN reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director ATKINS M SHAN received a stock award rather than buying shares on the market. On June 17, 2026, the director was granted 108,324 Common Shares in the form of restricted stock units at a price of $0.00 per share as compensation. These RSUs vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026 and March 29, 2027. After this grant, the director directly holds 149,714 Common Shares.
Lazzarato David Angelo reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director David Angelo Lazzarato received an equity award of 162,485 Common Shares on June 17, 2026. The award was granted at no cash cost to him as a compensation-related grant, not an open-market purchase.
The grant was made in the form of restricted stock units that vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026, and March 29, 2027. Following this grant, he directly holds 234,533 Common Shares.
BAYERN JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director Joseph Bayern received an equity award of 108,324 common shares on June 17, 2026. The shares were granted as restricted stock units, a form of stock-based compensation awarded at no cash cost to him.
These RSUs vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026, and March 29, 2027, aligning incentives over time. Following this grant, Bayern directly holds 148,324 common shares.
Yanofsky Theresa reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director Theresa Yanofsky received an equity award of 108,324 common shares on June 17, 2026. The shares were granted at no cash cost as restricted stock units (RSUs) and will vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026 and March 29, 2027. After this grant, Yanofsky directly holds 161,469 common shares, reflecting her ongoing equity stake in the company.
Canopy Growth Corp officer Stewart Thomas Carlton reported a mix of equity award grants and a small share sale. He received 379,018 Common Shares as restricted stock units granted on June 17, 2026, which vest in three equal installments on June 15, 2027, June 15, 2028, and June 15, 2029. He was also granted 463,347 stock options exercisable at $0.99 per share, vesting annually over three years from the same grant date and expiring on June 17, 2032. On the same day, he disposed of 9,285 Common Shares at an average price of $0.9741, with the footnotes stating this disposition was tied to tax obligations from earlier RSU vesting. After these transactions, he directly held 616,398 Common Shares and 463,347 stock options.
Canopy Growth Corp officer Christelle Gedeon reported equity compensation changes. On June 17, 2026, she received a grant of 484,122 stock options with an exercise price of $0.99 per share, vesting in three equal annual installments and expiring on June 17, 2032.
On the same date she acquired 396,012 common shares and sold 58,994 common shares at $0.9741 per share, with the disposition associated with tax obligations from RSU vesting. After these transactions she directly held 705,506 common shares. The transactions were not reported as made under a Rule 10b5-1 trading plan.
Canopy Growth Corp Chief Executive Officer Luc Mongeau reported a mix of equity compensation grants and a share disposition. He received 1,056,152 common shares in the form of restricted stock units (RSUs), which vest in three equal installments on June 15, 2027, June 15, 2028 and June 15, 2029. He was also granted stock options for 1,291,139 common shares with a conversion price of $0.99 per share, vesting in three equal annual installments on the first, second and third anniversaries of June 17, 2026 and expiring on June 17, 2032. On the same date, 135,231 common shares were disposed of at $0.9741 per share in connection with tax obligations arising from the vesting of RSUs granted on June 3, 2025. Following these transactions, Mongeau directly holds 1,723,913 common shares.
Canopy Growth Corporation reported fourth-quarter and full-year 2026 results showing modest revenue growth but ongoing losses. Net revenue reached about C$71.2 million in Q4 FY2026, up 10% from a year earlier, and C$284.6 million for FY2026, a 6% annual increase driven by 20% growth in Canadian adult-use cannabis and 18% growth in Canadian medical cannabis. International medical cannabis revenue grew 68% in Q4 but declined 7% for the year, while Storz & Bickel device revenue fell 14% both in the quarter and full year.
Reported gross margin compressed to 12% in Q4 and 24% for FY2026, though adjusted gross margin improved to 27% in Q4 after excluding acquisition-related inventory charges. The company posted a FY2026 net loss from continuing operations of C$262.9 million, about 49% narrower than FY2025, and an adjusted EBITDA loss of C$20.2 million. Free cash outflow improved significantly to C$69.1 million from C$176.6 million, and Canopy ended FY2026 with C$364.7 million in cash and a net cash position of C$131 million following a recapitalization. Management expects net revenue growth, better margins, lower operating costs and positive adjusted EBITDA in FY2027.